chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Aspiration joint, COVID-19, Chest X-ray normal, Cough
Clinical narrative: Discharge Provider: DO Primary Care Provider at Discharge: MD  Admission Date: 9/26/2022 Discharge Date: 10/4/2022   PRESENTING PROBLEM: Hypoxia [R09.02] Hypervolemia, unspecified hypervolemia type [E87.70] COVID-19 [U07.1]   HOSPITAL COURSE: 82-year-old gentleman presents with a 10 day history of nausea vomiting and diarrhea.  Patient with very poor oral intake.  He also has a non productive, dry, hacky cough.  Denies any shortness of breath.  Patient noted some dizziness and had a fall while at home.  Because of persistence of his symptoms and developing dizziness patient was concerned about dehydration so came to the emergency department.  Workup in the emergency department was positive for COVID 19. Patient did have some hypoxemia which was transient in the emergency department which has since resolved.  Currently patient is on room air.  Patient was outside the window for remdesivir.  Chest x-ray does not have significant abnormalities.  Today patient is doing better.  No diarrhea since presentation.     Patient's oxygenation remained stable throughout hospitalization.  He was maintained on 2 L per nasal cannula it was eventually weaned she to off.  Patient's diarrhea was slow to resolve.  He did have a short course of vancomycin pending culture results.  Patient did not produce sample that could be tested for C difficile, because of improvement stools patient's oral vancomycin was discontinued.  There is no evidence of C difficile at this time.  Patient also still required intermittent oxygen.  With volume resuscitation patient started exhibiting signs possible congestive heart failure.  He was placed on IV diuretics with good results.     Patient also complained of knee pain during hospitalization.  Orthopedics was consulted and He underwent a left arthrocentesis.  It was consistent with a gouty arthritis.  Patient was given a short course of steroid with good results.       Patient was evaluated by Physical therapy and Occupational therapy who recommended home health care.  Patient underwent oxygen study on the day of discharge.  He qualified for oxygen with activity.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Culture, Diarrhoea, Dizziness, Fall, Gouty arthritis
Clinical narrative: Discharge Provider: DO Primary Care Provider at Discharge: MD  Admission Date: 9/26/2022 Discharge Date: 10/4/2022   PRESENTING PROBLEM: Hypoxia [R09.02] Hypervolemia, unspecified hypervolemia type [E87.70] COVID-19 [U07.1]   HOSPITAL COURSE: 82-year-old gentleman presents with a 10 day history of nausea vomiting and diarrhea.  Patient with very poor oral intake.  He also has a non productive, dry, hacky cough.  Denies any shortness of breath.  Patient noted some dizziness and had a fall while at home.  Because of persistence of his symptoms and developing dizziness patient was concerned about dehydration so came to the emergency department.  Workup in the emergency department was positive for COVID 19. Patient did have some hypoxemia which was transient in the emergency department which has since resolved.  Currently patient is on room air.  Patient was outside the window for remdesivir.  Chest x-ray does not have significant abnormalities.  Today patient is doing better.  No diarrhea since presentation.     Patient's oxygenation remained stable throughout hospitalization.  He was maintained on 2 L per nasal cannula it was eventually weaned she to off.  Patient's diarrhea was slow to resolve.  He did have a short course of vancomycin pending culture results.  Patient did not produce sample that could be tested for C difficile, because of improvement stools patient's oral vancomycin was discontinued.  There is no evidence of C difficile at this time.  Patient also still required intermittent oxygen.  With volume resuscitation patient started exhibiting signs possible congestive heart failure.  He was placed on IV diuretics with good results.     Patient also complained of knee pain during hospitalization.  Orthopedics was consulted and He underwent a left arthrocentesis.  It was consistent with a gouty arthritis.  Patient was given a short course of steroid with good results.       Patient was evaluated by Physical therapy and Occupational therapy who recommended home health care.  Patient underwent oxygen study on the day of discharge.  He qualified for oxygen with activity.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Hypervolaemia, Hypophagia, Hypoxia, Nausea, Vomiting
Clinical narrative: Discharge Provider: DO Primary Care Provider at Discharge: MD  Admission Date: 9/26/2022 Discharge Date: 10/4/2022   PRESENTING PROBLEM: Hypoxia [R09.02] Hypervolemia, unspecified hypervolemia type [E87.70] COVID-19 [U07.1]   HOSPITAL COURSE: 82-year-old gentleman presents with a 10 day history of nausea vomiting and diarrhea.  Patient with very poor oral intake.  He also has a non productive, dry, hacky cough.  Denies any shortness of breath.  Patient noted some dizziness and had a fall while at home.  Because of persistence of his symptoms and developing dizziness patient was concerned about dehydration so came to the emergency department.  Workup in the emergency department was positive for COVID 19. Patient did have some hypoxemia which was transient in the emergency department which has since resolved.  Currently patient is on room air.  Patient was outside the window for remdesivir.  Chest x-ray does not have significant abnormalities.  Today patient is doing better.  No diarrhea since presentation.     Patient's oxygenation remained stable throughout hospitalization.  He was maintained on 2 L per nasal cannula it was eventually weaned she to off.  Patient's diarrhea was slow to resolve.  He did have a short course of vancomycin pending culture results.  Patient did not produce sample that could be tested for C difficile, because of improvement stools patient's oral vancomycin was discontinued.  There is no evidence of C difficile at this time.  Patient also still required intermittent oxygen.  With volume resuscitation patient started exhibiting signs possible congestive heart failure.  He was placed on IV diuretics with good results.     Patient also complained of knee pain during hospitalization.  Orthopedics was consulted and He underwent a left arthrocentesis.  It was consistent with a gouty arthritis.  Patient was given a short course of steroid with good results.       Patient was evaluated by Physical therapy and Occupational therapy who recommended home health care.  Patient underwent oxygen study on the day of discharge.  He qualified for oxygen with activity.
Age: 82.0
Sex: F
Vaccine: PNC20
Symptoms: Injection site haemorrhage, Injection site mass, Injection site pain
Clinical narrative: Patient came in to get 2 vaccination: flu and pneumonia vaccine. After getting both vaccines, patient came back with left arm bleeding more than usual. Upon cleaning the area, it stopped bleeding , but there is a lump with diameter around 1 inch. Patient did not feel painful to touch on the lump at first, but later she said she felt a bit pain. Patient was instructed to wait for 15 minutes to monitor any other side effects. After 15 minutes, patient did not have any additional side effects. Patient was instructed to take Benadryl and if the lump gets worse, patient will call the pharmacy or the doctor.
Age: 45.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Injection site discharge
Clinical narrative: Nurse states vaccine leaked from patient's left arm during ID administration; patient did not receive full dose. Same nurse repeated ID administration on the same arm (left arm) successfully. No patient complications noted.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Bronchial wall thickening, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal
Clinical narrative: Discharge Provider:MD Primary Care Provider: MD Admission Date: 9/26/2022 Discharge Date: 10/4/22  PRESENTING PROBLEM: Shortness of breath [R06.02] Cough [R05.9] Pneumonia due to COVID-19 virus [U07.1, J12.82]   HOSPITAL COURSE: Patient is a 73-year-old male with a history of chronic obstructive pulmonary disease, myeloid neoplasm, BPH, GERD, peripheral arterial disease and prior COVID infection who presented with right-sided chest pain and dyspnea.  Patient tested positive for COVID in early August and had completed a course of PAC Slo-bid. In the ER he was found to be tachypneic and hypoxic requiring 2 L of oxygen.  COVID-19 test was positive.  Chest x-ray showed increased bronchial thickening in the posterior lung bases which could represent inflammatory or infectious bronchitis.  CT chest was obtained that showed severe emphysema as well as nodal a past Cities in the right upper lobe with central cavitation which could be infectious or inflammatory. It was felt patient had acute hypoxic respiratory failure secondary to COVID-19 pneumonia and there was also concern for secondary bacterial pneumonia.  Pulmonology was consulted and patient was started on remdesivir and Decadron.  He completed 5 day course of remdesivir.  Also placed on ceftriaxone and azithromycin and completed a 7 day course. Fungal studies were negative, TB screening indeterminate. Patient then developed worsening hypoxia with increasing oxygen needs.  He was placed on scheduled nebs as well as Symbicort and Spiriva.  He was placed on Solu-Medrol and once his respiratory status had improved, he was transitioned back to dexamethasone. Oxygen needs decreased and he was only requiring 1-2 L of oxygen. As D-dimer was elevated, lower extremity Dopplers were obtained which did not reveal any evidence of DVT Patient did have leukocytosis but had elevated WBC at baseline due to his underlying myeloid neoplasm.  Hematology was consulted and they noted that there was no transformation to acute leukemia and no indication to start inpatient therapy.  As WBCs did increase to over 100, he was given 1 dose of Hydrea 1000 mg and white coun did improve to 96.76. Pulmonology recommended that patient complete a total of 10 days of dexamethasone. Patient was weaned off oxygen to room air.   Patient was seen by pulmonary rehab and was not felt to require oxygen therapy. He was to be followed by Medical Group bridging Older Adult Care program after discharge.   Patient discharged home in stable condition 10/4/22.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Computerised tomogram thorax abnormal, Cough, Dyspnoea, Emphysema
Clinical narrative: Discharge Provider:MD Primary Care Provider: MD Admission Date: 9/26/2022 Discharge Date: 10/4/22  PRESENTING PROBLEM: Shortness of breath [R06.02] Cough [R05.9] Pneumonia due to COVID-19 virus [U07.1, J12.82]   HOSPITAL COURSE: Patient is a 73-year-old male with a history of chronic obstructive pulmonary disease, myeloid neoplasm, BPH, GERD, peripheral arterial disease and prior COVID infection who presented with right-sided chest pain and dyspnea.  Patient tested positive for COVID in early August and had completed a course of PAC Slo-bid. In the ER he was found to be tachypneic and hypoxic requiring 2 L of oxygen.  COVID-19 test was positive.  Chest x-ray showed increased bronchial thickening in the posterior lung bases which could represent inflammatory or infectious bronchitis.  CT chest was obtained that showed severe emphysema as well as nodal a past Cities in the right upper lobe with central cavitation which could be infectious or inflammatory. It was felt patient had acute hypoxic respiratory failure secondary to COVID-19 pneumonia and there was also concern for secondary bacterial pneumonia.  Pulmonology was consulted and patient was started on remdesivir and Decadron.  He completed 5 day course of remdesivir.  Also placed on ceftriaxone and azithromycin and completed a 7 day course. Fungal studies were negative, TB screening indeterminate. Patient then developed worsening hypoxia with increasing oxygen needs.  He was placed on scheduled nebs as well as Symbicort and Spiriva.  He was placed on Solu-Medrol and once his respiratory status had improved, he was transitioned back to dexamethasone. Oxygen needs decreased and he was only requiring 1-2 L of oxygen. As D-dimer was elevated, lower extremity Dopplers were obtained which did not reveal any evidence of DVT Patient did have leukocytosis but had elevated WBC at baseline due to his underlying myeloid neoplasm.  Hematology was consulted and they noted that there was no transformation to acute leukemia and no indication to start inpatient therapy.  As WBCs did increase to over 100, he was given 1 dose of Hydrea 1000 mg and white coun did improve to 96.76. Pulmonology recommended that patient complete a total of 10 days of dexamethasone. Patient was weaned off oxygen to room air.   Patient was seen by pulmonary rehab and was not felt to require oxygen therapy. He was to be followed by Medical Group bridging Older Adult Care program after discharge.   Patient discharged home in stable condition 10/4/22.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Fibrin D dimer increased, Fungal test negative, Hypoxia, Leukocytosis, Lung opacity
Clinical narrative: Discharge Provider:MD Primary Care Provider: MD Admission Date: 9/26/2022 Discharge Date: 10/4/22  PRESENTING PROBLEM: Shortness of breath [R06.02] Cough [R05.9] Pneumonia due to COVID-19 virus [U07.1, J12.82]   HOSPITAL COURSE: Patient is a 73-year-old male with a history of chronic obstructive pulmonary disease, myeloid neoplasm, BPH, GERD, peripheral arterial disease and prior COVID infection who presented with right-sided chest pain and dyspnea.  Patient tested positive for COVID in early August and had completed a course of PAC Slo-bid. In the ER he was found to be tachypneic and hypoxic requiring 2 L of oxygen.  COVID-19 test was positive.  Chest x-ray showed increased bronchial thickening in the posterior lung bases which could represent inflammatory or infectious bronchitis.  CT chest was obtained that showed severe emphysema as well as nodal a past Cities in the right upper lobe with central cavitation which could be infectious or inflammatory. It was felt patient had acute hypoxic respiratory failure secondary to COVID-19 pneumonia and there was also concern for secondary bacterial pneumonia.  Pulmonology was consulted and patient was started on remdesivir and Decadron.  He completed 5 day course of remdesivir.  Also placed on ceftriaxone and azithromycin and completed a 7 day course. Fungal studies were negative, TB screening indeterminate. Patient then developed worsening hypoxia with increasing oxygen needs.  He was placed on scheduled nebs as well as Symbicort and Spiriva.  He was placed on Solu-Medrol and once his respiratory status had improved, he was transitioned back to dexamethasone. Oxygen needs decreased and he was only requiring 1-2 L of oxygen. As D-dimer was elevated, lower extremity Dopplers were obtained which did not reveal any evidence of DVT Patient did have leukocytosis but had elevated WBC at baseline due to his underlying myeloid neoplasm.  Hematology was consulted and they noted that there was no transformation to acute leukemia and no indication to start inpatient therapy.  As WBCs did increase to over 100, he was given 1 dose of Hydrea 1000 mg and white coun did improve to 96.76. Pulmonology recommended that patient complete a total of 10 days of dexamethasone. Patient was weaned off oxygen to room air.   Patient was seen by pulmonary rehab and was not felt to require oxygen therapy. He was to be followed by Medical Group bridging Older Adult Care program after discharge.   Patient discharged home in stable condition 10/4/22.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Mycobacterium tuberculosis complex test, Pulmonary mass, SARS-CoV-2 test positive, Tachypnoea, Ultrasound Doppler normal
Clinical narrative: Discharge Provider:MD Primary Care Provider: MD Admission Date: 9/26/2022 Discharge Date: 10/4/22  PRESENTING PROBLEM: Shortness of breath [R06.02] Cough [R05.9] Pneumonia due to COVID-19 virus [U07.1, J12.82]   HOSPITAL COURSE: Patient is a 73-year-old male with a history of chronic obstructive pulmonary disease, myeloid neoplasm, BPH, GERD, peripheral arterial disease and prior COVID infection who presented with right-sided chest pain and dyspnea.  Patient tested positive for COVID in early August and had completed a course of PAC Slo-bid. In the ER he was found to be tachypneic and hypoxic requiring 2 L of oxygen.  COVID-19 test was positive.  Chest x-ray showed increased bronchial thickening in the posterior lung bases which could represent inflammatory or infectious bronchitis.  CT chest was obtained that showed severe emphysema as well as nodal a past Cities in the right upper lobe with central cavitation which could be infectious or inflammatory. It was felt patient had acute hypoxic respiratory failure secondary to COVID-19 pneumonia and there was also concern for secondary bacterial pneumonia.  Pulmonology was consulted and patient was started on remdesivir and Decadron.  He completed 5 day course of remdesivir.  Also placed on ceftriaxone and azithromycin and completed a 7 day course. Fungal studies were negative, TB screening indeterminate. Patient then developed worsening hypoxia with increasing oxygen needs.  He was placed on scheduled nebs as well as Symbicort and Spiriva.  He was placed on Solu-Medrol and once his respiratory status had improved, he was transitioned back to dexamethasone. Oxygen needs decreased and he was only requiring 1-2 L of oxygen. As D-dimer was elevated, lower extremity Dopplers were obtained which did not reveal any evidence of DVT Patient did have leukocytosis but had elevated WBC at baseline due to his underlying myeloid neoplasm.  Hematology was consulted and they noted that there was no transformation to acute leukemia and no indication to start inpatient therapy.  As WBCs did increase to over 100, he was given 1 dose of Hydrea 1000 mg and white coun did improve to 96.76. Pulmonology recommended that patient complete a total of 10 days of dexamethasone. Patient was weaned off oxygen to room air.   Patient was seen by pulmonary rehab and was not felt to require oxygen therapy. He was to be followed by Medical Group bridging Older Adult Care program after discharge.   Patient discharged home in stable condition 10/4/22.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: White blood cell count increased
Clinical narrative: Discharge Provider:MD Primary Care Provider: MD Admission Date: 9/26/2022 Discharge Date: 10/4/22  PRESENTING PROBLEM: Shortness of breath [R06.02] Cough [R05.9] Pneumonia due to COVID-19 virus [U07.1, J12.82]   HOSPITAL COURSE: Patient is a 73-year-old male with a history of chronic obstructive pulmonary disease, myeloid neoplasm, BPH, GERD, peripheral arterial disease and prior COVID infection who presented with right-sided chest pain and dyspnea.  Patient tested positive for COVID in early August and had completed a course of PAC Slo-bid. In the ER he was found to be tachypneic and hypoxic requiring 2 L of oxygen.  COVID-19 test was positive.  Chest x-ray showed increased bronchial thickening in the posterior lung bases which could represent inflammatory or infectious bronchitis.  CT chest was obtained that showed severe emphysema as well as nodal a past Cities in the right upper lobe with central cavitation which could be infectious or inflammatory. It was felt patient had acute hypoxic respiratory failure secondary to COVID-19 pneumonia and there was also concern for secondary bacterial pneumonia.  Pulmonology was consulted and patient was started on remdesivir and Decadron.  He completed 5 day course of remdesivir.  Also placed on ceftriaxone and azithromycin and completed a 7 day course. Fungal studies were negative, TB screening indeterminate. Patient then developed worsening hypoxia with increasing oxygen needs.  He was placed on scheduled nebs as well as Symbicort and Spiriva.  He was placed on Solu-Medrol and once his respiratory status had improved, he was transitioned back to dexamethasone. Oxygen needs decreased and he was only requiring 1-2 L of oxygen. As D-dimer was elevated, lower extremity Dopplers were obtained which did not reveal any evidence of DVT Patient did have leukocytosis but had elevated WBC at baseline due to his underlying myeloid neoplasm.  Hematology was consulted and they noted that there was no transformation to acute leukemia and no indication to start inpatient therapy.  As WBCs did increase to over 100, he was given 1 dose of Hydrea 1000 mg and white coun did improve to 96.76. Pulmonology recommended that patient complete a total of 10 days of dexamethasone. Patient was weaned off oxygen to room air.   Patient was seen by pulmonary rehab and was not felt to require oxygen therapy. He was to be followed by Medical Group bridging Older Adult Care program after discharge.   Patient discharged home in stable condition 10/4/22.
Age: 9.0
Sex: M
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Administered vaccine 10/5 @ 11:16am. Injection site red and swollen- noted 10/6 at 8am
Age: 17.0
Sex: F
Vaccine: PNC13
Symptoms: Exposure during pregnancy, Wrong product administered
Clinical narrative: Patient is currently 33 weeks pregnant - was given PCV 13 instead of FLU Vaccine
Age: 14.0
Sex: M
Vaccine: COVID19-2
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: none
Age: 75.0
Sex: F
Vaccine: COVID19-2
Symptoms: Condition aggravated, Pain in extremity
Clinical narrative: patient called complaining of sore arm. she said shes been icing and using tylenol however it is not improving but not getting worse. recommended if the sore arm continues to go see a doctor but explained sore arm is common side effect with vaccine
Age: 54.0
Sex: F
Vaccine: COVID19-2, FLUA4
Symptoms: Arthralgia, Injection site pain, Musculoskeletal discomfort, Musculoskeletal stiffness, Myalgia
Clinical narrative: Initial discomfort in left shoulder (covid vaccination arm) and pain/stiffness on left side of neck.  The following day or two I had minor cold symptoms (stuffy nose, muscle aches, sore throat, etc.).  Now, two weeks post vaccination I still have all symptoms.  The pain in my shoulder is so bad that I've seen a chiropractor and doctor.  I am unable to lay on my left side while sleeping because I still have pain at the injection site.  My "cold" symptoms have persisted throughout this time.
Age: 54.0
Sex: F
Vaccine: COVID19-2, FLUA4
Symptoms: Nasal congestion, Nasopharyngitis, Neck pain, Oropharyngeal pain, Sleep disorder
Clinical narrative: Initial discomfort in left shoulder (covid vaccination arm) and pain/stiffness on left side of neck.  The following day or two I had minor cold symptoms (stuffy nose, muscle aches, sore throat, etc.).  Now, two weeks post vaccination I still have all symptoms.  The pain in my shoulder is so bad that I've seen a chiropractor and doctor.  I am unable to lay on my left side while sleeping because I still have pain at the injection site.  My "cold" symptoms have persisted throughout this time.
Age: 39.0
Sex: F
Vaccine: FLU4
Symptoms: Rash erythematous, Vaccination site rash
Clinical narrative: Localized erythematous rash to area of vaccination on l upper arm. Also a preexisting mosquito bite on the same arm of vaccination.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: No symptoms noted at time of administration. Administered monovalent for booster inadvertently.
Age: 4.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose normal, Cyanosis, Dizziness, Febrile convulsion, Hypotonia
Clinical narrative: On 8/9/22 was outside playing.  Came in from outside and feel backwards.  Initially limp 1-2 minutes, then became stiff and tightened whole body for about 2-3 minutes noted body appeared purplish blue.  After five minutes started moving arms and hands and by 10 minutes was normal.  EMS was called and transported child to local ER.  Discharge diagnosis was febrile seizure.  Follow up patient has no further events or illnesses.
Age: 4.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza A virus test negative, Influenza virus test negative, Musculoskeletal stiffness, Respiratory syncytial virus test negative, SARS-CoV-2 test negative
Clinical narrative: On 8/9/22 was outside playing.  Came in from outside and feel backwards.  Initially limp 1-2 minutes, then became stiff and tightened whole body for about 2-3 minutes noted body appeared purplish blue.  After five minutes started moving arms and hands and by 10 minutes was normal.  EMS was called and transported child to local ER.  Discharge diagnosis was febrile seizure.  Follow up patient has no further events or illnesses.
Age: 71.0
Sex: F
Vaccine: FLU4
Symptoms: Tremor
Clinical narrative: Patient called to report experiencing tremors or uncontrollable shaking all over.  Pharmacist recommended a visit to urgent care if not resolved in 15-20 minutes
Age: 64.0
Sex: F
Vaccine: UNK
Symptoms: Dysarthria, Flushing, Pharyngeal swelling, Swollen tongue
Clinical narrative: Patient came back to office within 30 mins of vaccine administration with tongue swelling and throat swelling. She was flushed in her cheeks and face. Speech became slurred due to tongue swelling. Patient was treated with 50 mg Benadryl. Patient waited in our office for an additional 30 mins after administration.
Age: 69.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Pain, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Has a fever and body aches on 4 days after injection and was also diagnosed with Covid on that day
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Antibody test positive, Antinuclear antibody negative, Blood test normal, Loss of personal independence in daily activities, Parosmia
Clinical narrative: In mid-July of 2022, I started noticing a change in things that I was smelling and tasting. The first thing I noticed was the taste of coffee. It seemed to get significantly worse over the next few months to the point where I now have very significant problems with a foul smell and taste on specific food and products. My smell has changed to the degree that I can no longer smell things that I used to be able to smell and now have a foul odor associated with certain things. At this point it is affecting daily activities. I can no longer tolerate coffee, eggs, peanut butter, onions, wheat bread, wheat cracker, chocolate, any type of alcohol. I can no longer smell the stench of a skunk, feces, strongly scented chemicals. Things that used to smell pleasant but now smell foul are hand soap, dish detergent, toothpaste. All of these things have dramatically changed my daily activities. I haven't been able to go out to restaurants and dine out with friends or enjoy a morning cup of coffee with my husband. I have seen a doctor who did a number of tests including an antibody test for both the vaccine and the virus. Two tests have confirmed that I do have some antibodies built up to the vaccine which was a pleasant surprise due to my immunity disorder, but I have no antibodies to the virus itself, so it has been confirmed that I have never had covid. These changes in smell and taste have also resulted in around an 8-pound weight loss.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Taste disorder, Weight decreased
Clinical narrative: In mid-July of 2022, I started noticing a change in things that I was smelling and tasting. The first thing I noticed was the taste of coffee. It seemed to get significantly worse over the next few months to the point where I now have very significant problems with a foul smell and taste on specific food and products. My smell has changed to the degree that I can no longer smell things that I used to be able to smell and now have a foul odor associated with certain things. At this point it is affecting daily activities. I can no longer tolerate coffee, eggs, peanut butter, onions, wheat bread, wheat cracker, chocolate, any type of alcohol. I can no longer smell the stench of a skunk, feces, strongly scented chemicals. Things that used to smell pleasant but now smell foul are hand soap, dish detergent, toothpaste. All of these things have dramatically changed my daily activities. I haven't been able to go out to restaurants and dine out with friends or enjoy a morning cup of coffee with my husband. I have seen a doctor who did a number of tests including an antibody test for both the vaccine and the virus. Two tests have confirmed that I do have some antibodies built up to the vaccine which was a pleasant surprise due to my immunity disorder, but I have no antibodies to the virus itself, so it has been confirmed that I have never had covid. These changes in smell and taste have also resulted in around an 8-pound weight loss.
Age: 63.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Cranial nerve disorder, Fatigue, Headache, Oropharyngeal pain
Clinical narrative: Headache, fatigue, cranky. Sore throat on 10/5/2022 and I tested, and it was positive. I started PAXLOVID last night and I also took ADVIL night. I don't feel too bad considering everything.
Age: 63.0
Sex: F
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Headache, fatigue, cranky. Sore throat on 10/5/2022 and I tested, and it was positive. I started PAXLOVID last night and I also took ADVIL night. I don't feel too bad considering everything.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Blood test normal, Chest discomfort, Electrocardiogram ambulatory abnormal, Laboratory test normal
Clinical narrative: I had vaccination on 04/06/2022. On the beginning of 06/2022 I started to experience Premature Ventricular Contractions. I contacted the Doctor that put me on the Eliquis because he is associated with a heart clinic. They put me on a Holter monitor they identified the sensations I was having was in fact Premature Ventricular Contractions with 500 episodes a day. The cardiologist said on 09/27/2022 that my tests and labs all look good.  I also started to experience symptoms of Phlebitis in 09/2022. I contacted my doctor and stated to double up on the Eliquis and to scale back on my exercise.  The Premature Ventricular Contractions gradually went away on their own.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Phlebitis, Ventricular extrasystoles
Clinical narrative: I had vaccination on 04/06/2022. On the beginning of 06/2022 I started to experience Premature Ventricular Contractions. I contacted the Doctor that put me on the Eliquis because he is associated with a heart clinic. They put me on a Holter monitor they identified the sensations I was having was in fact Premature Ventricular Contractions with 500 episodes a day. The cardiologist said on 09/27/2022 that my tests and labs all look good.  I also started to experience symptoms of Phlebitis in 09/2022. I contacted my doctor and stated to double up on the Eliquis and to scale back on my exercise.  The Premature Ventricular Contractions gradually went away on their own.
Age: 12.0
Sex: F
Vaccine: FLU4
Symptoms: Dizziness, Flushing, Paraesthesia, Streptococcus test negative, Throat irritation
Clinical narrative: Patient reports feeling tingling, throat itchy, feeling flushed, feeling as if she could pass out. No full syncope noted.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Diarrhoea, Nausea, Pyrexia, Vomiting
Clinical narrative: fever, abdominal pain, diarrhea, nausea, vomiting
Age: 29.0
Sex: F
Vaccine: VARCEL
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: no symptoms at time of administration. Given monovalent Moderna for booster inadvertently.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain
Clinical narrative: sore throat
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Asthenia, COVID-19, Dizziness, Headache
Clinical narrative: 12/16/21-12/17/21 observation. C/O weakness, lightheaded, HA, tested + in hospital, dx with transient hypotension,  UTI, acute renal failure
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Hypotension, SARS-CoV-2 test positive, Urinary tract infection
Clinical narrative: 12/16/21-12/17/21 observation. C/O weakness, lightheaded, HA, tested + in hospital, dx with transient hypotension,  UTI, acute renal failure
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Arteriovenous fistula, Aspartate aminotransferase increased, C-reactive protein increased, Cardiac imaging procedure abnormal, Chest pain
Clinical narrative: Chest pain starting about 1.5 days after his vaccination. He presented to the hospital 3.5 days after his vaccination.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Echocardiogram normal, Electrocardiogram PR segment depression, Electrocardiogram ST segment depression, Electrocardiogram ST segment elevation, Electrocardiogram abnormal
Clinical narrative: Chest pain starting about 1.5 days after his vaccination. He presented to the hospital 3.5 days after his vaccination.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Myocarditis, Red blood cell sedimentation rate increased, Troponin increased
Clinical narrative: Chest pain starting about 1.5 days after his vaccination. He presented to the hospital 3.5 days after his vaccination.
Age: 40.0
Sex: F
Vaccine: COVID19-2
Symptoms: Hypoaesthesia, Injection site bruising, Injection site pain, Paraesthesia
Clinical narrative: Site: Bruising at Injection Site-Mild, Site: Pain at Injection Site-Mild, Additional Details: I was notified of this today 10/3/2022 by store corporate risk management.  I'm not aware if patient notified us of this event prior.  Patient experienced tingling and numbness in arm and palm after vaccination.
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: The patient was given the vaccine 3 days past the expiration date.
Age: 69.0
Sex: M
Vaccine: FLU4
Symptoms: Injection site pain, Injection site swelling, Pain, Tenderness
Clinical narrative: Site: Swelling at Injection Site-Medium, Additional Details: pt states he has pain and soreness areas surrounding the injection site of his right arm pt states having pain level of 2 when you go to touch or move that arm. pt was counseled to use icing and ibuprofen for a couple of days to help alleviate these reactions.
Age: 35.0
Sex: M
Vaccine: COVID19-2
Symptoms: Seizure
Clinical narrative: Patients caregiver informed faculty that patient experienced seizure approximately 48 hours after receiving vaccination. Patient was hospitalized and appears to be recovering.
Age: 62.0
Sex: F
Vaccine: FLUA4
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: FLUAD given to patient < 65 years of age
Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: Cough, Diarrhoea, Fatigue, Headache, Nasal congestion
Clinical narrative: It started out with headache and fatigue in a day I had a headache and was nauseous I started having congestion both nose and then cough I eventually had a fever and diarrhea this lasted seven days and I had a fever that lasted eight days I could not bring it down so I called my doctor and started on an antibiotic..
Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pyrexia, SARS-CoV-2 test negative
Clinical narrative: It started out with headache and fatigue in a day I had a headache and was nauseous I started having congestion both nose and then cough I eventually had a fever and diarrhea this lasted seven days and I had a fever that lasted eight days I could not bring it down so I called my doctor and started on an antibiotic..
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Student was given the Pfizer vaccine indicated for those 12 years and older.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Injection site rash, Injection site swelling, Pain
Clinical narrative: Body aches head ache swollen arm rash in injection site exhaustion
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Atrial fibrillation, Computerised tomogram, Dysarthria, Dyskinesia, Hypertension
Clinical narrative: I was sitting down; I was talking to my daughter, and I was slurring your words and looked like I was having a stroke. She gave you water and could not take it in because I couldn?t control the left of your mouth and called 911 and went to the hospital by ambulance. In the stroke ward. Afib was escalating and got a intravenous drip Diltiazem. They determined a mini stroke with no lasting damage. I was there from 14 to 16 Sep22. I do have a whizzing in my chest as I slept three after I came home from the hospital. High Blood Pressure has been up and down for several.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Magnetic resonance imaging head abnormal, Transient ischaemic attack, Wheezing
Clinical narrative: I was sitting down; I was talking to my daughter, and I was slurring your words and looked like I was having a stroke. She gave you water and could not take it in because I couldn?t control the left of your mouth and called 911 and went to the hospital by ambulance. In the stroke ward. Afib was escalating and got a intravenous drip Diltiazem. They determined a mini stroke with no lasting damage. I was there from 14 to 16 Sep22. I do have a whizzing in my chest as I slept three after I came home from the hospital. High Blood Pressure has been up and down for several.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Cough, Dyspnoea, Myalgia, Speech disorder
Clinical narrative: cough, SOB, back pain, myalgias, speech difficulty
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Head discomfort, Malaise, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Covid symptoms started on 08/14/2022; tested positive on 08/15/2022. I started running a fever of 100.5 and I went to urgent care. I also had congestion in my head. Symptoms lasted through that Saturday 08/20/2022. I checked to see if I was still positive a week later and I was but didn't feel sick at all. I went for an infusion.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: The patient was expecting to get the Pfizer Bivalent Covid vaccine, but was given another booster dose of the monovalent instead. This was due to the nearly identical packaging of the mono- and bi-valent vaccine, and lack of double-checking the vial.  No adverse affects occurred.
Age: 75.0
Sex: F
Vaccine: COVID19-2
Symptoms: Arthralgia, Chills, Condition aggravated, Headache, Insomnia
Clinical narrative: Patient reports she received the Moderna Bivalent booster at approximately 1:30pm on 9/26/22.  By approximatley 7:00pm the same evening she began not feeling well with muscle aches, headache, difficulty sleepingand increased joint pain (more than typical for her), chills, then feeling hot.  Reports symptoms progressively got worse of the next few days and she did not feel back to herself until Monday, October 3, 2022.  She reports she did not contact her PCP or receive any other medical care during this time.  Reports no adverse symptoms after receiving any other COVID-19 vaccines.
Age: 75.0
Sex: F
Vaccine: COVID19-2
Symptoms: Malaise, Myalgia
Clinical narrative: Patient reports she received the Moderna Bivalent booster at approximately 1:30pm on 9/26/22.  By approximatley 7:00pm the same evening she began not feeling well with muscle aches, headache, difficulty sleepingand increased joint pain (more than typical for her), chills, then feeling hot.  Reports symptoms progressively got worse of the next few days and she did not feel back to herself until Monday, October 3, 2022.  She reports she did not contact her PCP or receive any other medical care during this time.  Reports no adverse symptoms after receiving any other COVID-19 vaccines.
Age: 69.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Chest pain
Clinical narrative: Severe chest pain worse with exercise
Age: 83.0
Sex: F
Vaccine: COVID19-2
Symptoms: Angiogram pulmonary abnormal, Dyspnoea, Pulmonary embolism
Clinical narrative: DEVELOPED SHORTNESS OF BREATH WITHIN 10-14 DAYS OF RECEIVING COVID BOOSTER. PATIENT WAS ADMITTED TO a local MEDICAL CENTER ON 10/3/2022 AFTER CT CHEST SHOWED PULMONARY EMBOLI.
Age: 58.0
Sex: F
Vaccine: COVID19-2
Symptoms: Arthritis, Condition aggravated, Ear pain, Headache, Pyrexia
Clinical narrative: Noticeable arthritis flare, beginning in jaw w/referred ear pain, Achilles heels, chest. 9/30  Progressing to multiple joints ? hips, lower back, shoulder, hands.  Low grade fever around 100 degrees Fahrenheit.  Constant headache.    Treatment Called dr for prednisone taper.  Started 10/5 not feeling better yet. Hopefully soon
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Full blood count, Oral herpes
Clinical narrative: after recieving the vaccination the patient had fever blisters appear around the entirety of her top and bottom lips of her face.
Age: 57.0
Sex: M
Vaccine: UNK
Symptoms: Vaccination error
Clinical narrative: Jaynneos vaccination error. Patient revaccinated.
Age: 6.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect dose administered, Product administered to patient of inappropriate age
Clinical narrative: This 6 year old patient received a Pfizer Bivalent Covid Booster age 12 yo and greater.  Patient mother was contacted all questions were answered to mother's satisfaction.  Mother verbalized understanding.  Patient had no adverse events at this time.  Patient Provider was contacted.
Age: 62.0
Sex: M
Vaccine: FLU4
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient received a dose of high-dose flu, even though he was only 62 years of age. The patient had reported the incorrect date of birth at first, and so the vaccinator didn't realize he was only 62 until after the vaccine was administered.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Pyrexia, Respiratory tract congestion
Clinical narrative: fever, congestion, cough
Age: 38.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Anaphylactic reaction, Chest discomfort, Dysphagia, Dyspnoea, Hypersensitivity
Clinical narrative: Within 8 hours, allergic reaction symptoms developed. Hives and swelling In legs and hands. Swelling in face and lips. Chest and throat tightness. Difficulty swallowing and taking deep breaths. Despite two doses of 50mg Benadryl spaced 4 hours apart, symptoms got worse. Went to Emergency Room.
Age: 38.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Lip swelling, Peripheral swelling, Swelling face, Throat tightness, Urticaria
Clinical narrative: Within 8 hours, allergic reaction symptoms developed. Hives and swelling In legs and hands. Swelling in face and lips. Chest and throat tightness. Difficulty swallowing and taking deep breaths. Despite two doses of 50mg Benadryl spaced 4 hours apart, symptoms got worse. Went to Emergency Room.
Age: 5.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received a booster dose on 10/5 and the product expired on9/30/2022
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Wrong product administered
Clinical narrative: Patient was expecting the Pfizer Bivalent booster, but was given another dose of mono-valent. No adverse reactions have occurred.  Error occurred due to the nearly identical packaging of both the mono- and bi- valent vaccines, and the lack of a double-check before injection.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Photopsia, Visual impairment, Vitreous floaters
Clinical narrative: Vision problems in right eye: Sudden onset of eye floaters and flashing light (semi-circle right side and lower left) in right eye.  No other symptoms.  Sought treatment the day after onset of symptoms from Dr. at Clinic. She used equipment to assess the condition of my eye and found that there were floaters but no retinal tears or separation. Advised to contact her in case symptoms worsened.
Age: 60.0
Sex: M
Vaccine: UNK
Symptoms: Vaccination error, Wrong technique in product usage process
Clinical narrative: Jaynneos vaccination error. Patient trvaccinated
Age: 80.0
Sex: M
Vaccine: COVID19-2
Symptoms: Arthralgia, Back pain, C-reactive protein, Computerised tomogram head, Full blood count
Clinical narrative: Progressive pain and weakness starting in (R) shoulder moving to (L) leg @ hip, then to (L) shoulder, to (R) leg, and eventually to upper back between shoulders. Some slight difficulty with speech and chewing.
Age: 80.0
Sex: M
Vaccine: COVID19-2
Symptoms: Magnetic resonance imaging head, Mastication disorder, Metabolic function test, Muscular weakness, Pain in extremity
Clinical narrative: Progressive pain and weakness starting in (R) shoulder moving to (L) leg @ hip, then to (L) shoulder, to (R) leg, and eventually to upper back between shoulders. Some slight difficulty with speech and chewing.
Age: 80.0
Sex: M
Vaccine: COVID19-2
Symptoms: Red blood cell sedimentation rate, Speech disorder, X-ray of pelvis and hip
Clinical narrative: Progressive pain and weakness starting in (R) shoulder moving to (L) leg @ hip, then to (L) shoulder, to (R) leg, and eventually to upper back between shoulders. Some slight difficulty with speech and chewing.
Age: 61.0
Sex: M
Vaccine: FLUR4
Symptoms: Cerebral palsy, Facial paralysis
Clinical narrative: pt has droopy face. he was diagnosed with cerebral palsy
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received booster dose 10/05/2022 and product expired 9/30/22
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: No adverse reactions have occurred.   Patient was expecting the Pfizer Bivalent booster, but was given another dose of mono-valent.  Error occurred due to the nearly identical packaging of both the mono- and bi- valent vaccines, and the lack of a double-check before injection.
Age: 2.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient was given second dose one week before due.
Age: 44.0
Sex: F
Vaccine: COVID19-2, UNK
Symptoms: Abdominal distension, Angiogram, Blood test, Chest X-ray, Dyspnoea
Clinical narrative: Armpit swelled, muscle cramping, fatigue, heart palpitations, elevated d dimer, shortness of breath, fevers feeling, swollen abdomen.
Age: 44.0
Sex: F
Vaccine: COVID19-2, UNK
Symptoms: Fatigue, Fibrin D dimer increased, Full blood count, Metabolic function test, Muscle spasms
Clinical narrative: Armpit swelled, muscle cramping, fatigue, heart palpitations, elevated d dimer, shortness of breath, fevers feeling, swollen abdomen.
Age: 44.0
Sex: F
Vaccine: COVID19-2, UNK
Symptoms: Oedema peripheral, Palpitations, Pyrexia
Clinical narrative: Armpit swelled, muscle cramping, fatigue, heart palpitations, elevated d dimer, shortness of breath, fevers feeling, swollen abdomen.
Age: 61.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: I did not have an adverse reaction to the vaccine.  This time of year, I have seasonal allergies every year. I had to be tested for COVID-19 prior to a medical procedure.  I went home and took a home test and it was positive on 09/27/2022. I went to the next level and had a NATT test and it confirmed COVID-19 positive on 09/27/2022.  My symptoms felt more like allergies, so I would never think I had COVID-19. I did not obtain a prescription due to my liver cirrhosis. As of today, I continue to test positive.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle spasms, Pain, Sleep disorder
Clinical narrative: I had my vaccination on 04/22/2021. I started having leg cramps a couple days after. I would go to bed and the pain was present within a few minutes. I take 2 of the Highland medications.  The pain was not present during the day. It would wake me up in the middle of night with pain. It was present daily, at night. I do have history of a lower back injury 2009. I try not to sit longer then 25 minutes and walk around. I had appt with PCM via zoom. The doctor stated for me to ice it and would have ultrasound if it repeated. The pain subsided.
Age: 1.0
Sex: F
Vaccine: MMR
Symptoms: Urticaria
Clinical narrative: Urticarial rash starting 7 days after the immunization, without fever, joint pain or swelling, that resolved after 7 days.
Age: 73.0
Sex: F
Vaccine: COVID19-2, UNK
Symptoms: Incorrect product formulation administered
Clinical narrative: She was supposed to receive the first primary covid 19 shot, but they gave her the bivalent booster.